🔬Colossal Biosciences Unveils GenoMorph for Dodo De-Extinction
GenoMorph aims to bring back the dodo with limited DNA
TL;DR
Colossal Biosciences introduces GenoMorph, an AI platform to aid in the dodo's de-extinction despite limited genetic data. GenoMorph identifies 2,300 DNA editing targets, focusing on precise genetic changes.
Colossal Biosciences has unveiled GenoMorph, an AI platform designed to accelerate de-extinction efforts, specifically targeting the dodo bird. With only one dodo genome compared to 100 for woolly mammoths, GenoMorph uses advanced 3D morphology and comparative genomics to identify key genes. This platform helps pinpoint the genetic switches responsible for the dodo's unique appearance, narrowing down 2,300 promising DNA editing targets. GenoMorph's precision is crucial for Colossal Biosciences as they aim to prove its predictions in a lab setting, potentially bringing back extinct species with fewer genetic data points.
Key Points
Colossal Biosciences' GenoMorph identifies 2,300 DNA editing targets for the dodo's unique facial structure.
GenoMorph uses 3D morphology and comparative genomics to pinpoint key genes for de-extinction projects.
The company has only one dodo genome compared to 100 for woolly mammoth projects, highlighting GenoMorph's efficiency.
Colossal Biosciences' Nicobar pigeon colony now has 36 birds, essential for genetic engineering research.
XPRIZE founder Peter Diamandis has backed Colossal Biosciences' programmable biology platform with his new VC firm, NeoGenesis Capital.
Why It Matters
GenoMorph helps Colossal Biosciences identify precise genetic changes for the dodo's de-extinction, focusing on 2,300 DNA editing targets. This technology makes genetic engineering more precise and testable, crucial for projects with limited genetic data. The platform's success could pave the way for other de-extinction efforts.
Comments
Be the first to comment
Enjoyed this article?
Get it daily. 7am. Free. Reads in 5 minutes.
Join 3,569 builders reading daily.